Immunoglobulin (IG) and T-cell receptor (TCR) clonality assays, IGHV somatic hypermutation assay and controls for IG/TCR assays
About This Opportunity
Supplies contract awarded by HUS Group (Finland): Immunoglobulin (IG) and T-cell receptor (TCR) clonality. healthcare. Awarded to Triolab Oy (0629706-0).
This is a supplies contract in the health and medical services, education and training and Research sectors. Located in Finland, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 700,000.
Published through Hilma Finland, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
HUSLAB Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is an SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic genetic testing services to all patients at Helsinki University Hospital area. The services include analysis of both constitutional samples and malignancies. The laboratory performs yearly approximately 300 immunoglobulin gene rearrangement studies, 450 T-cell receptor rearrangement studies, and 150 immunoglobulin gene V-region hypermutation studies.
The HUS Group requests tenders for IG/TCR clonality and somatic hypermutation assay reagents and controls for these reagents. The procurement is divided into two (2) lots, as follows:
1. Immunoglobulin (IG) and T-cell receptor (TCR) clonality assays and IGHV somatic hypermutation assay
2. Controls for IG/TCR assays
The tenderers may leave a tender to one or more lots as they decide.
The products that are included to the procurement are described in more detail in below in the invitation to tender. The subject matter of the procurement also includes additional products related to the products tendered, such as additional sizes and accessories. In addition, during the contract period, products belonging to the product groups that are the subject of the contract, may be acquired in accordance with the estimated value of the contract, also when they are not specified in the product annex (please see draft agreement).
This is not a joint procurement of several contracting entities and the products requested in this invitation to tender will be used by HUS Group (HUS).
The Agreement is in force for a fixed period of one (1) year, and thereafter until terminated.
The total estimated value of the procurement (VAT 0 %) is approximately EUR 700 000. This is an estimate and the contracting entity does not commit neither to the stated euro amounts and nor the consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated.
The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes., Immunoglobulin (IG) and T-cell receptor (TCR) clonality assays and IGHV somatic hypermutation assay In this lot 1 the contracting entity requests tenders for IG/TCR clonality and somatic hypermutation assay reagents., Controls for IG/TCR assays In this lot 2 the contracting entity requests tenders for controls for IG/TCR clonality.,
Lot 1: Immunoglobulin (IG) and T-cell receptor (TCR) clonality assays and IGHV somatic hypermutation assay
In this lot 1 the contracting entity requests tenders for IG/TCR clonality and somatic hypermutation assay reagents.
Lot 2: Controls for IG/TCR assays
In this lot 2 the contracting entity requests tenders for controls for IG/TCR clonality.
CPV: 33000000
Organisation: HUS Group
Procedure: open
Data provenance
This notice is sourced from Hilma Finland and was originally published on March 15, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About HUS Group
HUS Group has issued 20 procurement notices on BidsFactory, including 10 currently open and 8 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and Governance & Public Administration. All notices are published for Finland. Notices are distributed via Hilma Finland and TED - Tenders Electronic Daily (EU). Most recent publication: May 15, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €700,000. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Finland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Hilma Finland to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Triolab Oy (0629706-0). The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by HUS Group in Finland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.